Class information for:
Level 1: THALASSEMIA MAJOR//MOL DIAGNOST BIOPHARMACEUT//BETA THALASSEMIA MAJOR

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
13767 752 25.8 60%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
2309 4089 IRON OVERLOAD//THALASSEMIA//DEFERASIROX

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 THALASSEMIA MAJOR Author keyword 13 22% 7% 54
2 MOL DIAGNOST BIOPHARMACEUT Address 7 67% 1% 6
3 BETA THALASSEMIA MAJOR Author keyword 5 17% 3% 25
4 BODY DISPROPORTION Author keyword 4 67% 1% 4
5 BETA THALASSAEMIA MAJOR Author keyword 4 30% 1% 11
6 THALASSAEMIA UNIT Address 4 24% 2% 14
7 THALASSAEMIA MAJOR Author keyword 3 21% 2% 14
8 AUXOENDOCRINOL UNIT Address 2 67% 0% 2
9 CLIN BIOL DEV AGE Address 2 67% 0% 2
10 PAEDIAT 29 Address 2 67% 0% 2

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 THALASSEMIA MAJOR 13 22% 7% 54 Search THALASSEMIA+MAJOR Search THALASSEMIA+MAJOR
2 BETA THALASSEMIA MAJOR 5 17% 3% 25 Search BETA+THALASSEMIA+MAJOR Search BETA+THALASSEMIA+MAJOR
3 BODY DISPROPORTION 4 67% 1% 4 Search BODY+DISPROPORTION Search BODY+DISPROPORTION
4 BETA THALASSAEMIA MAJOR 4 30% 1% 11 Search BETA+THALASSAEMIA+MAJOR Search BETA+THALASSAEMIA+MAJOR
5 THALASSAEMIA MAJOR 3 21% 2% 14 Search THALASSAEMIA+MAJOR Search THALASSAEMIA+MAJOR
6 SHORT TRUNK 2 67% 0% 2 Search SHORT+TRUNK Search SHORT+TRUNK
7 IRON LACTATE 2 50% 0% 3 Search IRON+LACTATE Search IRON+LACTATE
8 ENDOCRINE COMPLICATIONS 1 38% 0% 3 Search ENDOCRINE+COMPLICATIONS Search ENDOCRINE+COMPLICATIONS
9 MENSTRUATING WOMEN 1 38% 0% 3 Search MENSTRUATING+WOMEN Search MENSTRUATING+WOMEN
10 BONE METABOLISM ETHANOL 1 100% 0% 2 Search BONE+METABOLISM+ETHANOL Search BONE+METABOLISM+ETHANOL

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MAJOR 11 100% 1% 6
2 THALASSEMIA MAJOR 8 11% 10% 72
3 ENDOCRINE COMPLICATIONS 7 42% 2% 13
4 NEUROSECRETORY DYSFUNCTION 6 40% 2% 12
5 SHORT CHINESE CHILDREN 6 100% 1% 4
6 ENDOCRINE ABNORMALITIES 5 35% 1% 11
7 HOMOZYGOUS BETA THALASSEMIA 5 18% 3% 23
8 COOLEYS ANEMIA 4 31% 2% 12
9 HOMOZYGOUS THALASSEMIA 3 100% 0% 3
10 INDUCED BONE DYSPLASIA 3 60% 0% 3

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Bone disease and skeletal complications in patients with beta thalassemia major 2011 27 89 88%
Growth and endocrine function in thalassemia major in childhood and adolescence 2010 13 99 93%
Iron homeostasis in osteoporosis and its clinical implications 2012 19 63 46%
Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials 2014 2 39 38%
Bisphosphonates in the treatment of thalassemia-associated osteoporosis 2008 13 24 75%
Growth, puberty and endocrine function in beta-thalassaemia major 1997 45 42 83%
New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia 2004 70 97 44%
The Spine in beta-Thalassemia Syndromes 2012 4 67 70%
The radiological appearances of thalassaemia 2006 12 14 86%
Complications of thalassemia major and their treatment 2011 15 102 33%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MOL DIAGNOST BIOPHARMACEUT 7 67% 0.8% 6
2 THALASSAEMIA UNIT 4 24% 1.9% 14
3 AUXOENDOCRINOL UNIT 2 67% 0.3% 2
4 CLIN BIOL DEV AGE 2 67% 0.3% 2
5 PAEDIAT 29 2 67% 0.3% 2
6 HAEMATOL WOMENS HLTH 1 100% 0.3% 2
7 MED THER Y UNIT 1 50% 0.3% 2
8 PEDIAT ADOLESCENT OUTPATIENT CLIN 1 50% 0.3% 2
9 PEDIAT MED ADOLESCENZA 1 100% 0.3% 2
10 S BAMBINO HOSP 1 100% 0.3% 2

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000256835 DEFERASIROX//IRON OVERLOAD//DEFERIPRONE
2 0.0000148476 NUTR GROWTH//PROPHYLACTIC TRANSFUSION//NUCLEO ACOES PESQUISA OIO DIAGNOST NUPAD
3 0.0000133411 INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA
4 0.0000123175 AHSP//ALPHA HEMOGLOBIN STABILIZING PROTEIN AHSP//ALPHA HEMOGLOBIN STABILIZING PROTEIN
5 0.0000073911 EXTRAMEDULLARY HEMATOPOIESIS//EXTRAMEDULLARY HAEMATOPOIESIS//EXTRAMEDULLARY HAEMOPOIESIS
6 0.0000071169 FERRIC SORBITOL CITRATE//FERRIC SORBITOL CITRATE FSC//NF KAPPA B EXPRESSION ACTIVATION
7 0.0000063116 IRON POISONING//IRON OVERDOSE//IRON INTOXICATION
8 0.0000058069 EIJKMAN IMMUNOL INFECT DIS//MALATTIE METAB FEGATO//NUCLEAR MICROSCOPY
9 0.0000040342 HEPATIC OSTEODYSTROPHY//LIMB REGENERAT//UNITE INSERM U658
10 0.0000037500 SPZ RHEUMATOL//MUSCLE BONE UNIT//PHYSIOL BIOMECAN PERFORMANCE MOTRICE